It is a broadly described annual report of Beximco Pharmaceuticals Limited in the year of 2010. During the year BPL achieved a net sales turnover of Taka. 6,490.85 million against Taka. 4,868.25 million in 2009 representing an impressive 33.33% increase while the industry grew at 23.81%. Export turnover increased by 21.47% to reach Taka. 330.54 million in the same period. Profit before tax increased to Taka. 1,361.53 million from Taka. 867.46 million in 2009. Earnings per share (EPS) stood at Taka. 5.17 against adjusted EPS of Taka. 3.50 in 2009.
The Board of Directors has recommended 20% stock dividend for approval of the shareholders for the year ended 31st December 2010. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.
More Annual Report of Beximco Pharmaceuticals Limited :
- Annual Report 2001 of Beximco Pharmaceuticals Limited
- Annual Report 2002 of Beximco Pharmaceuticals Limited
- Annual Report 2003 of Beximco Pharmaceuticals Limited
- Annual Report 2004 of Beximco Pharmaceuticals Limited
- Annual Report 2005 of Beximco Pharmaceuticals Limited
- Annual Report 2006 of Beximco Pharmaceuticals Limited
- Annual Report 2007 of Beximco Pharmaceuticals Limited
- Annual Report 2008 of Beximco Pharmaceuticals Limited
- Annual Report 2009 of Beximco Pharmaceuticals Limited
- Annual Report 2010 of Beximco Pharmaceuticals Limited
- Annual Report 2011 of Beximco Pharmaceuticals Limited
- Annual Report 2012 of Beximco Pharmaceuticals Limited
- Annual Report 2013 of Beximco Pharmaceuticals Limited
- Annual Report 2014 of Beximco Pharmaceuticals Limited
- Auditors’ Report 2015 of Beximco Pharmaceuticals Limited
- Annual Report 2016 of Beximco Pharmaceuticals Limited
- Auditors’ Report 2017 of Beximco Pharmaceuticals Limited
